Skip to content
Disclosery

PharVision Advisers, LLC: OGE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on OGE, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 0 OGE shares at 2026-03-31 per its 13F-HR/A filed 2026-05-11.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F/A 0 shares
    Change vs previous 13F -6,614 shares

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 6,614 shares
    Change vs previous 13F +675 shares

    0.14% of the 13F portfolio, value $282,418.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 5,939 shares
    Change vs previous 13F +877 shares

    0.15% of the 13F portfolio, value $274,798.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 5,062 shares
    Change vs previous 13F +5,062 shares

    0.32% of the 13F portfolio, value $224,652.

    13F-HR 0001420506-25-001926 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -12,179 shares

    13F-HR 0001420506-25-001232 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  6. period ended2024-12-31
    13F 12,179 shares
    Change vs previous 13F not available

    0.42% of the 13F portfolio, value $502,384.

    13F-HR 0001420506-25-000626 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).